Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Huailong, Xu"'
Autor:
Shiqi, Li, Jiasi, Zhang, Lvzhe, Chen, Huailong, Xu, Liping, He, Lin, Liu, Qianzhen, Zhang, Zhongtao, Yuan, Junjie, Shen, Zucong, Chen, Yingzi, Zhang, Meiling, Wang, Yunyan, Li, Linling, Wang, Lihua, Fang, Yingnian, Chen, Wei, Zhu, Yu, Li, Le, Luo, Youcheng, Wang, Dingsong, Zhang, Yancheng, Dong, Ping, Yin, Lihua, Zhang, Xiaoping, Li, Xiaozhuang, Hu, Zhongzheng, Zheng, Zhi, Yang, Cheng, Qian, Sanbin, Wang
Publikováno v:
In Molecular Therapy - Oncolytics 15 June 2023 29:107-117
Autor:
Yongliang Liu, Guiqin Wang, Jiasi Zhang, Xue Chen, Huailong Xu, Gang Heng, Jun Chen, Yongchun Zhao, Jiatao Li, Yuanli Ni, Yingzi Zhang, Juanjuan Shan, Cheng Qian
Publikováno v:
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2021)
Abstract Background Leukemia stem cells (LSCs) are responsible for the initiation, progression, and relapse of acute myeloid leukemia (AML). Therefore, a therapeutic strategy targeting LSCs is a potential approach to eradicate AML. In this study, we
Externí odkaz:
https://doaj.org/article/e696e57e595e4d75a8f4f6cf2bf6a72b
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Circulating tumor DNA (ctDNA) is a promising biomarker for accurate monitoring and less invasive assessment of tumor burden and treatment response. Here, targeted next-generation sequencing (NGS) with a designed gene panel of 176 cancer-relevant gene
Externí odkaz:
https://doaj.org/article/dd7b1348e1c64e3a96adf5f3bb31700f
Autor:
Meiling Wang, Qianzhen Zhang, Juanjuan Shan, Mingyuan Li, Chao Yao, Yanhe Guo, Huailong Xu, Jingxia Liu, Xuejiao Chen, Jian-Ming Li, Junjie Shen, Hong Juan, Zhi Yang, Zhao Wenxu, Hua Wu, Yanmin Xu, Qi Yanan, Qinghua Ma, Jun Chen, Cheng Qian
Publikováno v:
Cancer Letters. 454:78-89
Patients with advanced hepatocellular carcinoma (HCC) will almost always develop acquired tolerance after sorafenib therapy, and the molecular mechanism of sorafenib tolerance remains poorly characterized. Here, using our established sorafenib-resist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d613c4a0014c5a8defcd7b5b64dfbd7
https://doi.org/10.1016/j.canlet.2019.03.049
https://doi.org/10.1016/j.canlet.2019.03.049
Autor:
Yuanli Ni, Guiqin Wang, Zhao Yongchun, Jiatao Li, Huailong Xu, Juanjuan Shan, Yingzi Zhang, Yongliang Liu, Cheng Qian, Jiasi Zhang, Xue Chen, Jun Chen, Gang Heng
Publikováno v:
Stem Cell Research & Therapy
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2021)
Stem Cell Research & Therapy, Vol 12, Iss 1, Pp 1-13 (2021)
Background Leukemia stem cells (LSCs) are responsible for the initiation, progression, and relapse of acute myeloid leukemia (AML). Therefore, a therapeutic strategy targeting LSCs is a potential approach to eradicate AML. In this study, we aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14f4a87b0d412bac1086e4c6b86a9d72
https://doi.org/10.21203/rs.3.rs-55355/v3
https://doi.org/10.21203/rs.3.rs-55355/v3
Autor:
Yongliang Liu, Guiqin Wang, Jiasi Zhang, Chen, Xue, Huailong Xu, Heng, Gang, Chen, Jun, Yongchun Zhao, Jiatao Li, Yuanli Ni, Yingzi Zhang, Juanjuan Shan, Qian, Cheng
Additional file 2: Figure S1. Flow cytometry was used to detect the expression of CD9 in AML cell lines. Figure S2. Flow cytometry detects the cell cycle of CD9+ and CD9- cells. *p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d303abfefe97927d4dc4195cea72e29
Autor:
Xue Chen, Jiatao Li, Gang Heng, Yongchun Zhao, Jun Chen, Huailong Xu, Yongliang Liu, Juanjuan Shan, Yuanli Ni, Guiqin Wang, Yingzi Zhang, Cheng Qian, Jiasi Zhang
Background: Leukemia stem cells (LSCs) are responsible for the initiation, progressing and relapse of acute myeloid leukemia (AML). Therefore, the therapy strategy of targeting LSCs is hopeful to eradicate AML. In this study, we aimed to identify LSC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::da92aec62bda69c7a227a846989d3a1d
https://doi.org/10.21203/rs.3.rs-55355/v2
https://doi.org/10.21203/rs.3.rs-55355/v2
Autor:
Huailong Xu, Xue Chen, Yongliang Liu, Limei Liu, Cheng Qian, Guiqin Wang, Jiasi Zhang, Juanjuan Shan, Yongchun Zhao, Yuanli Ni, Jiatao Li, Jun Chen, Gang Heng, Yingzi Zhang
Background: Leukemia stem cells (LSCs) are responsible for the initiation, progress and relapse of acute myeloid leukemia (AML). Therefore, the therapy strategy of targeting LSCs is hopeful to eradicate AML. In this study, we aim to identify LSC-spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4465b95f51fe71c85b67d383e3e1032
https://doi.org/10.21203/rs.3.rs-55355/v1
https://doi.org/10.21203/rs.3.rs-55355/v1
Autor:
Limei Liu, Meiling Wang, Chengcheng Zhang, Haijun Zhou, Junyu Xiang, Cheng Qian, Juan Feng, Huailong Xu, Junjie Shen, Guiqin Wang, Matías A. Avila, Jun Chen, Hui Sun, Zhi Yang, Li Su, Chungang Liu, Juanjuan Shan, Ni Zhang, Jesús Prieto
Publikováno v:
Gastroenterology. 158(3)
Background & Aims Immune checkpoint inhibitors have some efficacy in the treatment of hepatocellular carcinoma (HCC). Programmed cell death 1 ligand 1 (PD-L1), expressed on some cancer cells, binds to the receptor programmed cell death 1 (PDCD1, also
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42387957e1d410d21e78a6aec958bd0e
https://pubmed.ncbi.nlm.nih.gov/31678303
https://pubmed.ncbi.nlm.nih.gov/31678303
Autor:
Min Wu, Zhi Yang, Zhihao Wei, Meiling Wang, Gang Heng, Jianyu Xia, Jiankun Jia, Limei Liu, Zhouxing Xiong, Chungang Liu, Guiqin Wang, Juanjuan Shan, Huailong Xu, Haijun Zhou, Cheng Qian, Hong Huang
Publikováno v:
Hepatology (Baltimore, Md.)References. 70(4)
Metabolic reprogramming endows cancer cells with the ability to adjust metabolic pathways to support heterogeneously biological processes. However, it is not known how the reprogrammed activities are implemented during differentiation of cancer stem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adafbc40e018b6bb41581a42c90484df
https://pubmed.ncbi.nlm.nih.gov/30901096
https://pubmed.ncbi.nlm.nih.gov/30901096